Use of traditional and complementary medicine for musculoskeletal diseases

Use of traditional and complementary medicine for musculoskeletal diseases

Background/aim: We aimed to determine the prevalence of traditional and complementary medicine (TCM) use among patients withmusculoskeletal disorders (MSDs) and to examine the methods used, frequency, and experienced benefits of therapies; the reasons forusing TCM; and the sources of information about therapies. We also compared demographic characteristics of users and nonusers ofTCM.Materials and methods: The descriptive study was conducted with 839 patients who attended the physical therapy and rehabilitationunits of 3 public hospitals between September 2014 and March 2015. A self-administered questionnaire including demographiccharacteristics, medical history, and details of TCM use was applied.Results: Of the 839 individuals in the study (592 female, 247 male; mean age 48.9 ± 13.0 years), 35.4% reported using TCM. Therewas no significant statistical difference between users and nonusers in terms of age, gender, body mass index, socioeconomic status,or educational level (P > 0.05). The disease duration of TCM users was significantly higher than that of nonusers (P < 0.05). The mostcommonly used TCM methods were balneotherapy (31%), herbal therapies (30%), wet cupping (22.2%), and massage-manipulationmethods (21.2%). Of TCM users, 75.1% were satisfied.Conclusion: The prevalence of TCM use and satisfaction levels are high in patients with MSDs. Physicians should be well informedabout TCM methods and raise the awareness of patients to prevent improper use of TCM.

___

  • 1. World Health Organization. General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine. WHO/EDM/TRM/2000. Geneva, Switzerland: WHO; 2000.
  • 2. Ben-Arye E, Frenkel M, Klein A, Scharf M. Attitudes toward integration of complementary and alternative medicine in primary care: perspectives of patients, physicians and complementary practitioners. Patient Educ Coun 2008; 70: 395- 402.
  • 3. Ernst E, Cohen MH, Stone J. Ethical problems arising in evidence based complementary and alternative medicine. J Med Ethics 2004; 30: 156-159.
  • 4. Grazio S, Balen D. Complementary and alternative treatment of musculoskeletal pain. Acta Clin Croat 2011; 50: 513-530.
  • 5. Artus M, Croft P, Lewis M. The use of complementary and alternative medicine and conventional treatments among primary care consulters with chronic musculoskeletal pain. BMC Family Practice 2007; 8: 26.
  • 6. Sullivan M, Rothfels P. Identifying and managing modifiable risk factors for chronic pain and disability. BC Med J 2012; 54: 152.
  • 7. Ulusoy H, Güçer TK, Aksu M, Arslan S, Habiboğlu A, Akgöl G, Bilgici A, Kuru Ö, Çetin I, Kamanlı A et al. The use of complementary and alternative medicine in Turkish patients with rheumatic diseases. Turk J Rheumatol 2012; 27: 31-37.
  • 8. Sherman KJ, Cherkin DC, Ichikawa L, Avins AL, Delaney K, Barlow WE, Khalsa PS, Deyo RA. Treatment expectations and preferences as predictors of outcome of acupuncture for chronic back pain. Spine (Phila Pa 1976) 2010; 35: 1471-1477.
  • 9. Louw A, Diener I, Butler DS, Puentedura EJ. The effect of neuroscience education on pain, disability, anxiety and stress in chronic musculoskeletal pain. Arch Phys Med Rehabil 2011; 92: 2041-2056.
  • 10. Avcı İA, Koç Z, Sağlam Z. Use of complementary and alternative medicine by patients with cancer in northern Turkey: analysis of cost and satisfaction. J Clin Nurs 2011; 21: 677-688.
  • 11. Aslan O, Vural H, Kömürcü S, Özet A. Use of complementary and alternative medicine by cancer patients in Turkey: a survey. J Altern Complement Med 2006; 12: 355-356.
  • 12. Erci B. Attitudes towards holistic complementary and alternative medicine: a sample of healthy people in Turkey. J Clin Nurs 2007; 16: 761-768.
  • 13. Ramsey SD, Spencer AC, Topolski TD, Belza B, Patrick DL. Use of alternative therapies by older adults with osteoarthritis. Arthritis Rheum 2001; 45: 222-227.
  • 14. Herman CJ, Allen P, Hunt WC, Prasad A, Brady TJ. Use of complementary therapies among primary care clinic patients with arthritis. Prev Chronic Dis 2004; 1: 12.
  • 15. Patterson C, Arthur H. A complementary alternative medicine questionnaire for young adults. Integr Med Insights 2009; 4: 1-11.
  • 16. Mbada CE, Adeyemi TL, Adedoyin RA, Badmus HD, Awotidebe TO, Arije OO, Omotosho OS. Prevalence and modes of complementary and alternative medicine use among peasant farmers with musculoskeletal pain in a rural community in South-Western Nigeria. BMC Compl Altern Med 2015; 6: 164.
  • 17. Mollaoğlu M, Acıyurt A. Use of complementary and alternative medicine among patients with chronic diseases. Acta Clin Croat 2013; 52: 181-188.
  • 18. Tokem Y, Parlar KS, Özer S, Nakaş D, Argon G. A multicenter analysis of the use of complementary and alternative medicine in Turkish patients with rheumatoid arthritis: holistic nursing practice review copy. Holis Nurs Pract 2014; 28: 98-105.
  • 19. Ndao-Brumblay SK, Green CR. Predictors of complementary and alternative medicine use in chronic pain patients. Pain Med 2010; 11: 16-24.
  • 20. Umay E, Rükşen S, Tezelli MK, Meşhur M, Dinç A. Evaluation of patient satisfaction. Turk J Phys Med Rehab 2013; 59: 222- 228.
  • 21. Rietjens IM, Boersma MG, Haan LD, Spenkelink B, Awad HM, Cnubben NH, Van Zanden JJ, Woude HV, Alink GM, Koeman JH. The pro-oxidant chemistry of the natural antioxidants vitamin C, vitamin E, carotenoids and flavonoids. Environ Toxicol Pharmacol 2002; 11: 321-333.
  • 22. Eke D, Çelik A. Curcumin prevents perfluorooctane sulfonateinduced genotoxicity and oxidative DNA damage in rat peripheral blood. Drug Chem Toxicol 2015; 7: 1-7.
  • 23. Datta S, Mahdi F, Ali Z, Jekabsons MB, Khan IA, Nagle DG, Zhou YD. Toxins in botanical dietary supplements: blue cohosh components disrupt cellular respiration and mitochondrial membrane potential. J Nat Prod 2014; 77: 111-117.
  • 24. El-Wakil A. Observations of the popularity and religious significance of blood-cupping as an Islamic medicine. Contemp Islamıc Studies 2011; 2: 1-12.
  • 25. Abdullah S, Dar LM, Rashid A, Tewari A. Hirudotherapy/ leech therapy: applications and indications in surgery. Arch Clin Exp Surg 2012; 1: 172-180.
  • 26. Cherkin DC, Deyo RA, Sherman KJ, Hart LG, Street JH, Hrbek A. Characteristics of visits to licensed acupuncturists, chiropractors, massage therapists and naturopathic physicians. J Am Board Fam Pract 2012; 15: 463-472.
  • 27. Chandola A, Young Y, McAlister J, Axford JS. Use of complementary therapies by patients attending musculoskeletal clinics. J Royal Soc Med 1999; 92: 13-16.
  • 28. Haetzman M, Elliott AM, Smith BH, Hannaford P, Chambers WA. Chronic pain and the use of conventional and alternative therapy. Fam Pract 2003; 20: 147-154
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Ahmet GURPINAR, Sibel Doğan GÜNAYDIN, Cengiz KILIÇ, Ayşen KARADUMAN

Validation and reliability study of the Turkish version of the Neuroquality of Life (Neuro-QoL)-Stigma Scale for neurological disorders

Nurdan KOTEVOĞLU, Sibel KARŞIDAĞ, Miruna Florentina ATEŞ, Şevki ŞAHİN, Nilgün ÇINAR

İlgin Yildirim ŞİMŞİR, Utku Erdem SOYALTIN, Banu Pinar Şarer YÜREKLİ, Mehmet ERDOĞAN, Şevki ÇETİNKALP, Lütfiye Füsun SAYGILI, Ayhan DÖNMEZ, Ahmet Gökhan ÖZGEN

Seda Aladağ KURT, Cem YÜCEL, Suna Özhan OKTAR, Gonca ERBAŞ, Tevfik Sinan SÖZEN, Ali Yusuf ÖNER

Clinical significance of progastrin-releasing peptide, neuron-specific enolase, chromogranin a, and squamous cell cancer antigen in pulmonary neuroendocrine tumors

Ömer ÖNAL, Cevat YAZICI, Olgun KONTAŞ, Fahrettin KELEŞTEMUR, Nuri TUTAR, Nur Aleyna YETKİN

Ali KÜPELİ, Eser BULUT, Ayşegül CANSU, Ali GÜNER, Mehmet SOYTÜRK, Gürkan DANIŞAN

Fatih FIRDOLAŞ, Necip PİRİNÇÇİ, Tunç OZAN, Ahmet KARAKEÇİ, İrfan ORHAN

Serum S100A12 and S100B proteins are independent predictors of the presence and severity of obstructive sleep apnea

İbrahim KILINÇ, Adil ZAMANİ, Şebnem YOSUNKAYA, Gözde DEMİRCİ SAĞLAM

Thyroid volumes and serum VEGF levels in dyslipidemic patients: effects of statin treatment

Neşe ERSÖZ GÜLÇELİK, Neşe ÇINAR, Murat TUNCEL, Firuzan Fırat ÖZER, Alper GÜRLEK, Meltem ÇAĞLAR, Kadriye AYDIN, Şafak AKIN, Aydan USMAN, Cafer BALCI

Bin XU, Di WU, Hong YING, Ying ZHANG